American Century Companies’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $743K | Buy |
57,146
+4,583
| +9% | +$59.6K | ﹤0.01% | 2387 |
|
|
2025
Q1 | $557K | Buy |
52,563
+5,545
| +12% | +$58.7K | ﹤0.01% | 2471 |
|
|
2024
Q4 | $798K | Buy |
47,018
+4,547
| +11% | +$77.2K | ﹤0.01% | 2334 |
|
|
2024
Q3 | $986K | Sell |
42,471
-59,568
| -58% | -$1.38M | ﹤0.01% | 2243 |
|
|
2024
Q2 | $2.48M | Sell |
102,039
-129,706
| -56% | -$3.16M | ﹤0.01% | 1820 |
|
|
2024
Q1 | $7.83M | Buy |
231,745
+215,799
| +1,353% | +$7.29M | ﹤0.01% | 1307 |
|
|
2023
Q4 | $503K | Sell |
15,946
-3,382
| -17% | -$107K | ﹤0.01% | 2355 |
|
|
2023
Q3 | $494K | Buy |
19,328
+5,635
| +41% | +$144K | ﹤0.01% | 2274 |
|
|
2023
Q2 | $393K | Buy |
+13,693
| New | +$393K | ﹤0.01% | 2311 |
|